Molecular diagnosis of the transthyretin (TTR) Met111 mutation in familial amyloid cardiomyopathy of Danish origin.
Familial amyloid cardiomyopathy in a Danish kindred is associated with a specific mutation (Met for Leu111) in the transthyretin (TTR) gene, causing the loss of a recognition site for the restriction enzyme DdeI in the gene. We describe a diagnostic test for the molecular detection of this mutation. A sequence of the TTR gene containing the mutation was amplified by the polymerase chain reaction from isolated genomic DNA of two affected patients and several controls. DdeI digestion of the amplified DNA from the patients revealed 3 bands by gel-electrophoresis, whereas amplified DNA of the controls showed only 2 bands, consistent with complete digestion. Thus, the assumed heterozygous TTR Met111 mutation was confirmed in the affected patients.
Nordvåg
B Y
BY
Department of Rheumatology, University Hospital of Tromsø, Norway.
Husby
G
G
Ranløv
I
I
el-Gewely
M R
MR
D000686:Amyloidosis / Q000175:diagnosis / Q000235:genetics*; D001483:Base Sequence; D009202:Cardiomyopathies / Q000175:diagnosis / Q000235:genetics*; D015257:DNA-Cytosine Methylases / Q000378:metabolism; D003718:Denmark; D006579:Heterozygote; D006801:Humans; D008715:Methionine / Q000235:genetics*; D008969:Molecular Sequence Data; D009154:Mutation / Q000235:genetics; D009838:Oligodeoxyribonucleotides / Q000235:genetics; D016133:Polymerase Chain Reaction; D011228:Prealbumin / Q000235:genetics*
D009838:Oligodeoxyribonucleotides; D011228:Prealbumin; D008715:Methionine; C050391:DNA modification methylase DdeI; D015257:DNA-Cytosine Methylases